573.63
-3.74 (-0.65%)
-3.74 (-0.65%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 1,110,087 |
|
|||||
News | - | ||||||
Day High | 577.51 | Low High |
|||||
Day Low | 568.19 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Thermo Fisher Scientific Inc | TMO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
574.90 | 568.19 | 577.51 | 573.63 | 577.37 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
29,079 | 1,110,087 | $ 573.37 | $ 636,486,642 | - | 475.77 - 618.355 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:09:58 | 1 | $ 569.37 | USD |
Thermo Fisher Scientific Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 224.98B | 392.20M | 391.64M | $ 39.21B | $ 6.31B | 19.45 | 32.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ 1.04 | 0.21% | 12/14/22 | -100.60k | 0.40% |
Thermo Fisher Scientific News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 583.60 | 609.85 | 566.925 | 588.93 | 1,848,980 | -9.97 | -1.71% |
1 Month | 552.80 | 609.85 | 522.78 | 572.51 | 1,885,835 | 20.83 | 3.77% |
3 Months | 493.27 | 609.85 | 483.73 | 553.30 | 1,567,702 | 80.36 | 16.29% |
6 Months | 573.01 | 611.06 | 475.77 | 545.68 | 1,455,832 | 0.62 | 0.11% |
1 Year | 567.24 | 618.355 | 475.77 | 550.29 | 1,460,070 | 6.39 | 1.13% |
3 Years | 327.36 | 672.34 | 250.21 | 481.97 | 1,567,513 | 246.27 | 75.23% |
5 Years | 219.40 | 672.34 | 194.51 | 399.41 | 1,482,649 | 354.23 | 161.45% |
Thermo Fisher Scientific Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%). |